FIELD: medicine.
SUBSTANCE: group of inventions relates to the chemical-pharmaceutical industry and is a use of a compound of formula IA or a pharmaceutically acceptable salt thereof
(IA), as well as using a combination of said compound and an additional therapeutic agent selected from: compounds IB, IC, neuroleptic agent, antiglutamatergic means, antiglutamatergic agent, dopamine-reducing agent, acetylcholinesterase inhibitor, for preventing or treating hyperkinetic movement disorder caused by Huntington's disease, Wilson's disease, Tourette's syndrome, restless leg syndrome or tardive dyskinesia.
EFFECT: group of inventions enables using compound IA and a combination of said compound with said therapeutic agents for a new purpose.
20 cl, 1 tbl, 1 ex
